Date | Detail |
---|---|
Dec. 13, 2022 |
BeiGene ASH 2022 ALPINE Late-Breaker Data Presentation
|
Dec 11, 2022 |
BeiGene ASH 2022 Data Presentation
|
Nov 16, 2022 |
The 13th Annual Jefferies Global Healthcare Conference
|
Nov 11, 2022 |
Cowen 6th Annual IO Next Summit
|
Sep 14, 2022 |
Morgan Stanley 20th Annual Global Healthcare Conference Webcast
|
Jun 14, 2022 |
Goldman Sachs 43rd Annual Global Healthcare Conference
|
Mar 07, 2022 |
Cowen 42nd Annual Health Care Virtual Conference
|
Feb 10, 2022 |
Guggenheim Healthcare Talks - 2022 Oncology Conference
|
Jan 11, 2022 |
BeiGene at the J.P. Morgan 40th Annual Healthcare Conference
|
Aug 25, 2021 |
BeiGene Investor Conference Call and Webcast to Discuss the Company’s Early Development Pipeline and Research
|
Jun 11, 2021 |
BeiGene Investor Conference Call and Webcast to Discuss the Company’s ALPINE study, EHA 2021 Presentations, and Update on Brukinsa Development
|
Jan 14, 2021 |
BeiGene at the J.P. Morgan 39th Annual Healthcare Conference
|
Dec 28, 2020 |
BeiGene 2020 China National Reimbursement Drug List (NRDL) Results Conference Call
|
Nov 23 - Dec 03, 2020 |
BeiGene at the Piper Sandler 32nd Annual Virtual Healthcare Conference
|
Sep 17, 2020 |
BeiGene at the Morgan Stanley 18th Annual Global Healthcare Conference
|
Jul 09, 2020 |
BeiGene Investor Conference Call and Webcast to Discuss the Company’s Early Development Pipeline and Research
|
Jun 10, 2020 |
BeiGene at Goldman Sachs 41st Annual Global Healthcare Conference
|
May 29, 2020 |
BeiGene to Discuss Clinical Study Results Presented at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program
|
Mar 27, 2020 |
BeiGene at the Bernstein 36th Annual Strategic Decisions Conference
|
Mar 03, 2020 |
BeiGene at Cowen and Company's 40th Annual Health Care Conference
|